APLAR - Congress Updates

Coverage of key data relating to the science of inflammatory diseases and new developing therapeutic options that target immune-mediated signalling pathways presented at key congresses and reviewed for your information.

December 05^th-09^th

Hong Kong
JAK Inhibitors: Are the Promises Fulfilled?

Our review and coverage of APLAR 2022 highlighting the most relevant data on cytokine signalling and new and developing therapeutic options that target cytokine signalling pathways, with our brochures highlighting the key posters and oral presentations ahead of the congress.

APLAR - Congress Updates

December 05th-09th

Hong Kong JAK Inhibitors: Are the Promises Fulfilled?

December 05^th-09^th

Hong Kong
JAK Inhibitors: Are the Promises Fulfilled?